(IDVA) iShares EURO STOXX Select - Ratings and Ratios

The iShares EURO STOXX Select Dividend30 UCITS ETF (DE) EUR Acc is an exchange-traded fund that tracks the Morningstar Developed Europe TME NR EUR index, providing investors with exposure to Eurozone large-cap equities with a focus on dividend-paying stocks.

This ETF is designed to capture the performance of 30 high-dividend-yielding stocks from the Eurozone, offering a relatively stable source of income in potentially volatile markets. The funds underlying index is constructed to emphasize dividend yield, which can be an attractive feature for income-seeking investors.

Analyzing the funds technical data, we observe that the current price is 6.42 EUR, slightly below its 20-day simple moving average (SMA) of 6.45 EUR, indicating a potential short-term bearish trend. However, the 50-day SMA at 6.14 EUR and the 200-day SMA at 5.52 EUR suggest a longer-term bullish trend, as the current price is significantly above both of these averages. The Average True Range (ATR) is 0.06, corresponding to a 0.91% daily volatility, which is relatively moderate.

From a fundamental perspective, the funds Assets Under Management (AUM) stand at 2380.00M EUR, indicating a substantial investor base and liquidity. This size can contribute to tighter bid-ask spreads and lower trading costs for investors.

Using both technical and fundamental data, a forecast for the IDVA ETF can be constructed. Given the current technical indicators and the funds focus on dividend-paying stocks, we can anticipate that the ETF will continue to attract income-seeking investors. If the Eurozone large-cap equity market continues to perform well, and dividend yields remain attractive compared to other asset classes, the IDVA ETF is likely to see sustained demand. Therefore, a potential price target could be in the range of 6.8 to 7.2 EUR in the next 6 to 12 months, assuming the 52-week high of 6.54 EUR is breached and the bullish trend continues. Conversely, a decline below the 50-day SMA could signal a correction, potentially testing the 200-day SMA at 5.52 EUR.